Dual antiplatelet therapy for acute coronary syndrome
Part of Heart & circulation clinical trials.
This trial tests giving two blood-thinning medicines early to people who have had a heart attack or unstable chest pain. Researchers want to see if this approach reduces future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a heart attack or unstable chest pain (acute coronary syndrome).
- You were prescribed blood-thinning medication while in the hospital.
- You agree to be contacted by phone or mail for up to one year after your hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether taking two blood thinners (aspirin plus clopidogrel or ticagrelor) after a heart stent procedure is safe and effective for people who already have low platelet counts. It may help doctors decide the best treatment for you if you have both low platelets and a stent.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This trial tests a shorter course of dual antiplatelet therapy (aspirin plus ticagrelor) after stent placement, switching early to just ticagrelor alone. It aims to see if this approach can safely reduce bleeding risks while still protecting against heart problems in people with stable coronary artery disease.
This trial tests whether patients who have had a heart attack or unstable angina and a stent placed with ultrasound guidance can safely stop one of their blood-thinning medicines early. It helps doctors find the best way to prevent future heart problems with fewer side effects.
This trial tests if taking two blood thinners (dual antiplatelet therapy) after a carotid artery stenting procedure is safe and effective for patients who have a higher risk of bleeding. It focuses on people with significant blockages in the neck arteries who are also at increased risk for serious bleeding or brain bleeds.
This study tests a tool to help patients with high bleeding and clotting risks decide on the best dual antiplatelet therapy after complex stent placement for a heart attack. Doctors and patients will use the decision aid together to find the safest treatment plan.
Hear when a new Major Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.